Abstracts
GRAPPA develops future thought leaders by hosting an annual Trainee Symposium each year during the GRAPPA Annual Meeting. Abstracts from around the world are submitted and the best are chosen to present.
The trainee symposium promotes the dissemination and discussion of research related to dermatology and rheumatology clinical, translational, and basic science proposals.
Sixteen abstract submissions were selected for poster presentations and five were selected for oral presentations at the 2024 GRAPPA Annual Meeting and Trainee Symposium held in Seattle, Washington, USA on July 11-13.
Oral Presenters
Joe Hutton University of Cambridge Characterisation of circulating pre-osteoclasts in psoriatic arthritis
Filippo Fagni University Clinic of Erlangen Psoriasis and Psoriatic Arthitis show metabolic similarities at the entheses at in vivo molecular imaging
Clementina Lopez-Medina Research Stay Pitié-Salpétrière Hospital PsAID thresholds defining disease symptoms/impact severity
Michelle Mulder Rijnstate Hospital Exploring the relationship between skin disease activity and the PASDAS in psoriatic arthritis
Ummugulsum Gazel University of Ottawa Validation of Handheld Ultrasound Devices for Point of Care Use in Rheumatology: Interim Analysis for Enthesitis
Poster Presenters
Accelerometer-measured daily steps in adults with psoriatic disease: a cross-sectional analysis of the UK Biobank
Trainee: Dylan McGagh
University of Oxford
Adverse events associated with oral small-molecule drugs in the treatment of psoriasis and psoriatic arthritis: a pharmacovigilance study based on the FAERS database
Trainee: Yuanyuan Xu
West China Hospital, Sichuan University
Association of Contextual Factors with Sonographic Inflammatory and Structural Phenotypes in Psoriatic Arthritis Patients
Trainee: Andre Lucas Ribeiro
Women's College Hospital, University of Toronto
Characterising Axial Inflammation in Psoriatic Patients Not Fulfilling ASAS axSpA Entry Criteria: Findings from the ATTRACT Study
Trainee: Alice Agostinelli
University Hospital of the Marche Region, Ancona, ITALY
Characteristics of patients with difficult to treat psoriatic arthritis: Results from e.Pulse, the Nationwide Health Data
Trainee: Gözde Sevgi Kart Bayram
Hacettepe University
Choice of Biologic Immunotherapy for Psoriasis or Psoriatic Arthritis Not Associated with Risk of Major Cardiac Events
Trainee: Bonit Gill
Clinical enthesitis concerns half the patients with psoriatic arthritis, is more frequent in trials than in observational studies and is assessed heterogeneously: a systematic review with meta-analysis of 84,262 patients from 212 studies
Trainee: Caroline Pignon
Correlation between the two questionnaires used to assess sexual function in psoriatic patients
Trainee: Gabriel Deves
Effects of secukinumab on enthesiophyte and erosion progression in psoriatic arthritis A one-year double-blind, randomized, placebo-controlled trial utilizing HR-pQCT
Identification and Characterization of the Tissue Resident Memorial T Cells in Psoriatic Arthritis: Regulatory Role in Chronicity and Treatment Response
IL-23 as biomarker of clinical response to apremilast in patients with psoriatic arthritis
Incidence and Predictors of Primary Failure of Advanced Therapy in Patients with Psoriatic Arthritis
Psoriasis and Psoriatic Arthitis show metabolic similarities at the entheses at in vivo molecular imaging with multispectral optoacoustic tomography – results from the MAPSA study
Psoriatic arthritis patient profiles are different between randomised controlled trials of biological disease-modifying antirheumatic drugs and a real-world study over the same timeframe (PsABio) - a literature review with meta-analysis.
Serum Calprotectin (S100A8/9) and Complement Factor C3 as Potential Inflammatory Markers in Obese and “CRP negative” Early PsA Patients: Data From a Multicenter METAPSA Cohort
The difference in disease impact between matched early psoriatic arthritis and rheumatoid arthritis patients before and after treatment
